Magnesium Salicylate

Magnesium salicylate is an organic compound with the chemical formula CHMgO₆ and a molecular weight of approximately 298.531 (some sources record it as 370.60, which may vary due to differences in water of crystallization or measurement methods). Its CAS Registry number is 18917-89-0, and its EINECS number is 242-669-3.

It belongs to the nonsteroidal anti-inflammatory drug (NSAID) class and has the following main pharmacological effects:

• Antipyretic
• Analgesic
• Anti-inflammatory
• Antirheumatic.

Its mechanism of action is mainly through inhibiting cyclooxygenase activity, reducing prostaglandin synthesis, thereby relieving pain and inflammation.

Magnesium salicylate is a nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and anti-inflammatory effects. Its applications are primarily focused on rheumatic and immune system diseases, pain management, and some metabolic-related conditions. Its main applications are as follows:

Main Applications

Arthritis Treatment

Suitable for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and degenerative osteoarthritis. Because it does not contain sodium ions, it is particularly suitable for patients with hypertension or heart failure.

Soft Tissue Rheumatism

Used for bursitis, tendinitis, and muscle soreness.

Analgesic Effect
Relieves mild to moderate pain, such as headaches, migraines, joint pain, and postoperative pain.

Antipyretic Effect
Used for fever caused by infectious diseases (such as colds and influenza).

Anti-inflammatory effects

Inhibits the cyclooxygenase (COX) pathway, reduces the production of inflammatory mediators such as prostaglandins, and alleviates inflammatory responses such as redness, swelling, heat, and pain.

Cholepromoting effects

Promotes bile secretion and excretion, improves biliary function, and can be used as an adjunct treatment for cholecystitis and cholelithiasis.

Antectorial effects (mentioned in some studies)

May exert its anticonvulsant effect by increasing GABA concentration in the brain and stabilizing neuronal membrane potential, but this use is rarely used as a first-line treatment in clinical practice.

Prevention of thrombosis (secondary effect)

Inhibits platelet aggregation, exhibiting antiplatelet activity, but its potency is weaker than aspirin, and it is generally not used as a primary indication for anticoagulation.

Shaanxi Yuantai Biotechnology Co., Ltd. was established in 2014, mainly supplying herbal extracts, functional cosmetic raw materials, organic products, etc. We have our own factories, R&D and quality inspection teams, and have the conditions for development, production, and quality assurance. At present, we have obtained ISO9001, ISO22000, HALAL, KOSHER, HACCP, FDA and other certificates. Therefore, the quality of our products is guaranteed, and it is our original intention to bring high-quality products to customers.

packaging

1KG/Aluminium bags , 25kg/barrel

Storage: Store in a cool, dry, clean place away from moisture and direct light.

We also have special packaging for special products, such as: retinal - cold chain transportation; deoxyarbutin - vacuum transportation